EMA — authorised 27 July 2020
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
EMA authorised Piqray on 27 July 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 27 July 2020.
Novartis Europharm Limited holds the EU marketing authorisation.